The government is engaging with the pharmaceutical sector to discuss policy, regulatory, and economic matters, with a focus on supporting growth, ensuring effective governance, and safeguarding patient interests. Discussions highlighted recent improvements in regulatory processes, digitalization, and progress toward international standards, as well as ways to boost investment, innovation, and export potential, said a press […]